JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garzón, J.
Right arrow Articles by Sánchez-Blázquez, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garzón, J.
Right arrow Articles by Sánchez-Blázquez, P.

Vol. 281, Issue 1, 549-557, 1997

Opioids Binding Mu and Delta Receptors Exhibit Diverse Efficacy in the Activation of Gi2 and Gx/z Transducer Proteins in Mouse Periaqueductal Gray Matter1

Javier Garzón, Antonio García-España and Pilar Sánchez-Blázquez

Neurofarmacología, Instituto de Neurobiología Santiago Ramón y Cajal, Consejo Superior de Investigaciones Científicas. Avenida Doctor Arce 37, 28002 Madrid, Spain

A nonisotopic, immunoelectrophoretic technique was used to analyze the characteristics of opioid-evoked activation of Gi2/Gx/z transducer proteins of mouse periaqueductal gray matter membranes. In the presence of picomolar concentrations of guanosine 5'-O-(3-thiotriphosphate), the opioid agonists promoted concentration-dependent increases of immunoreactivity associated with free Gi2alpha and Gx/zalpha subunits. [D-Ala2,N-MePhe4,Gly-ol5]enkephalin and morphine (preferential agonists at mu opioid receptors) and beta -endorphin-(1-31) (an agonist at mu/delta opioid receptors) activated Gx/z proteins. In contrast, the agonists of delta opioid receptors, [D-Ala2]deltorphin II and [D-Pen2,5]enkephalin, displayed little or no activity on this pertussis toxin resistant regulatory protein. Although exhibiting diverse efficacy, all the opioids studied activated Gi2 transducer proteins. [D-Ala2,N-MePhe4,Gly-ol5]enkephalin and [D-Ala2]deltorphin II were more potent at Gi2alpha subunits than at Gx/zalpha subunits. The opioid antagonist naloxone displayed a competitive profile in reducing the activation of G proteins promoted by morphine. Moreover, [D-Pen2,5]enkephalin antagonized the releasing effect exerted by [D-Ala2]deltorphin II on Gi2alpha and Gx/zalpha subunits. N,N-diallyl-Tyr-Aib-Aib-Phe-Leu (ICI-174864) reduced the Galpha -related immunosignals promoted by agonists of delta opioid receptors. Therefore, it is suggested that opioids exhibit marked differences in efficacy and/or potency in the activation of Gi2 and Gx/z transducer proteins in mouse periaqueductal gray matter.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.